These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6858823)

  • 21. Severe neutropenia associated with sustained-release procainamide.
    Ellrodt AG; Murata GH; Riedinger MS; Stewart ME; Mochizuki C; Gray R
    Ann Intern Med; 1984 Feb; 100(2):197-201. PubMed ID: 6691661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Procainamide-induced agranulocytosis and thrombocytopenia.
    Rothman IK; Amorosi EL
    Arch Intern Med; 1979 Feb; 139(2):246-7. PubMed ID: 434983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procainamide and neutropenia.
    Ann Intern Med; 1984 May; 100(5):766-7. PubMed ID: 6712043
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical use of sustained-release procainamide in treatment of cardiac arrhythmias.
    Michelson EL; McGeehin FC; Levin BK
    Angiology; 1988 Jul; 39(7 Pt 2):647-54. PubMed ID: 3044199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Agranulocytosis caused by procainamide (Pronestyl)].
    Hensen A
    Ned Tijdschr Geneeskd; 1974 Apr; 118(17):624-5. PubMed ID: 4133296
    [No Abstract]   [Full Text] [Related]  

  • 26. Procainamide-induced agranulocytosis: report of two cases and review.
    Nagesh KG; Poulose KP; Tseng TH; Schadchehr A
    J Kans Med Soc; 1980 Jan; 81(1):18-24. PubMed ID: 6153211
    [No Abstract]   [Full Text] [Related]  

  • 27. Lidocaine and procainamide toxicity during treatment of ventricular arrhythmias.
    Mattea J; Mattea E
    Am J Nurs; 1976 Sep; 76(9):1429-31. PubMed ID: 1048862
    [No Abstract]   [Full Text] [Related]  

  • 28. The assessment of an antiarrhythmic agent, sustained-release procainamide, with the aid of Holter monitoring.
    Bauer GE; Mitchell AS; Bates F; Hellestrand K
    Med J Aust; 1977 Nov; 2(22):733-5. PubMed ID: 347229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrophysiology and pharmacology of cardiac arrhythmias. VII. Cardiac effects of quinidine and procaine amide. A.
    Hoffman BF; Rosen MR; Wit AL
    Am Heart J; 1975 Jun; 89(6):804-8. PubMed ID: 1130271
    [No Abstract]   [Full Text] [Related]  

  • 30. Neutropenia associated with procainamide.
    Kimmel DP; Antignano LV; Barold SS; Boros L; Olson JP
    N Y State J Med; 1985 May; 85(5):197. PubMed ID: 3859759
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparative bioequivalence and efficacy of two sustained-release procainamide formulations in patients with cardiac arrhythmias.
    Hilleman DE; Patterson AJ; Mohiuddin SM; Ortmeier BG; Destache CJ
    Drug Intell Clin Pharm; 1988; 22(7-8):554-8. PubMed ID: 2458219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Arrhythmia prophylaxis with procaine amide: plasma concentrations in relation to dose.
    Collste P; Karlsson E
    Acta Med Scand; 1973 Nov; 194(5):405-11. PubMed ID: 4757219
    [No Abstract]   [Full Text] [Related]  

  • 33. Update on quinidine and procainamide.
    Cohen MN
    Angiology; 1982 Jul; 33(7):454-63. PubMed ID: 7091775
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of a sustained release procainamide preparation.
    Flanagan AD
    Angiology; 1982 Feb; 33(2):71-7. PubMed ID: 7039427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversible severe anaemia and granulocytopenia caused by procainamide. A case report.
    van Beek RJ; Bieger R; den Ottolander GJ
    Scand J Haematol; 1978 Aug; 21(2):150-2. PubMed ID: 694426
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Procaine amide-induced agranulocytosis].
    Tuominen L; Konttinen YP
    Duodecim; 1972; 88(10):717-20. PubMed ID: 5068887
    [No Abstract]   [Full Text] [Related]  

  • 37. Sustained release procainamide in patients with myocardial infarction.
    Birkhead J; Evans T; Mumford P; Martinez E; Jewitt D
    Br Heart J; 1976 Jan; 38(1):77-80. PubMed ID: 1252299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Letter: Time-dependent effect of oral procainamide in patients with exertional arrhythmias.
    Levy RH; Gey GO; Bruce RA
    J Pharm Sci; 1974 Dec; 63(12):1958-9. PubMed ID: 4449032
    [No Abstract]   [Full Text] [Related]  

  • 39. Immediate-release and sustained-release procainamide: bioavailability at steady state in cardiac patients.
    Vlasses PH; Rocci ML; Porrini KA; Greenspon AJ; Ferguson RK
    Ann Intern Med; 1983 May; 98(5 Pt 1):613-4. PubMed ID: 6189438
    [No Abstract]   [Full Text] [Related]  

  • 40. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
    Kalin ML; Babich MF; Klinke WP; Hui WK
    Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.